A Combination of Two Receptor Tyrosine Kinase Inhibitors, Canertinib and PHA665752 Compromises Ovarian Cancer Cell Growth in 3D Cell Models.
about
A Combination of Two Receptor Tyrosine Kinase Inhibitors, Canertinib and PHA665752 Compromises Ovarian Cancer Cell Growth in 3D Cell Models.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
A Combination of Two Receptor ...... Cell Growth in 3D Cell Models.
@en
A Combination of Two Receptor ...... Cell Growth in 3D Cell Models.
@nl
type
label
A Combination of Two Receptor ...... Cell Growth in 3D Cell Models.
@en
A Combination of Two Receptor ...... Cell Growth in 3D Cell Models.
@nl
prefLabel
A Combination of Two Receptor ...... Cell Growth in 3D Cell Models.
@en
A Combination of Two Receptor ...... Cell Growth in 3D Cell Models.
@nl
P2093
P2860
P1433
P1476
A Combination of Two Receptor ...... Cell Growth in 3D Cell Models.
@en
P2093
Ashley Garrill
Kenny Chitcholtan
Peter Sykes
Wafaa Hassan
P2860
P2888
P304
P356
10.1007/S40487-016-0031-1
P577
2016-09-27T00:00:00Z